Interpace Biosciences, Inc. (IDXG)
OTCMKTS · Delayed Price · Currency is USD
1.280
+0.210 (19.63%)
Apr 10, 2025, 3:34 PM EDT

Interpace Biosciences Statistics

Total Valuation

IDXG has a market cap or net worth of 5.66 million. The enterprise value is 10.06 million.

Market Cap 5.66M
Enterprise Value 10.06M

Important Dates

The next estimated earnings date is Friday, April 11, 2025.

Earnings Date Apr 11, 2025
Ex-Dividend Date n/a

Share Statistics

IDXG has 4.42 million shares outstanding. The number of shares has increased by 260.54% in one year.

Current Share Class n/a
Shares Outstanding 4.42M
Shares Change (YoY) +260.54%
Shares Change (QoQ) +1,024.21%
Owned by Insiders (%) 22.25%
Owned by Institutions (%) 3.25%
Float 3.44M

Valuation Ratios

The trailing PE ratio is 3.12.

PE Ratio 3.12
Forward PE n/a
PS Ratio 0.12
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio 1.50
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 1.10, with an EV/FCF ratio of 2.67.

EV / Earnings 1.61
EV / Sales 0.21
EV / EBITDA 1.10
EV / EBIT 1.24
EV / FCF 2.67

Financial Position

The company has a current ratio of 1.11

Current Ratio 1.11
Quick Ratio 0.94
Debt / Equity n/a
Debt / EBITDA 0.64
Debt / FCF 1.55
Interest Coverage 12.30

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) 36.32%
Return on Invested Capital (ROIC) 173.90%
Return on Capital Employed (ROCE) 194.11%
Revenue Per Employee 422,757
Profits Per Employee 56,198
Employee Count 108
Asset Turnover 3.36
Inventory Turnover 13.95

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -11.72% in the last 52 weeks. The beta is 0.64, so IDXG's price volatility has been lower than the market average.

Beta (5Y) 0.64
52-Week Price Change -11.72%
50-Day Moving Average 1.17
200-Day Moving Average 1.74
Relative Strength Index (RSI) 58.95
Average Volume (20 Days) 6,007

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.05

Income Statement

In the last 12 months, IDXG had revenue of 46.93 million and earned 6.24 million in profits. Earnings per share was 0.39.

Revenue 46.93M
Gross Profit 29.93M
Operating Income 8.11M
Pretax Income 6.95M
Net Income 6.24M
EBITDA 8.41M
EBIT 8.11M
Earnings Per Share (EPS) 0.39
Full Income Statement

Balance Sheet

The company has 1.46 million in cash and 5.86 million in debt, giving a net cash position of -4.40 million or -0.99 per share.

Cash & Cash Equivalents 1.46M
Total Debt 5.86M
Net Cash -4.40M
Net Cash Per Share -0.99
Equity (Book Value) -2.22M
Book Value Per Share -0.50
Working Capital 1.16M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.65 million and capital expenditures -876,000, giving a free cash flow of 3.77 million.

Operating Cash Flow 4.65M
Capital Expenditures -876,000
Free Cash Flow 3.77M
FCF Per Share 0.85
Full Cash Flow Statement

Margins

Gross margin is 63.77%, with operating and profit margins of 17.28% and 14.28%.

Gross Margin 63.77%
Operating Margin 17.28%
Pretax Margin 14.81%
Profit Margin 14.28%
EBITDA Margin 17.92%
EBIT Margin 17.28%
FCF Margin 8.03%

Dividends & Yields

IDXG does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -260.54%
Shareholder Yield -260.54%
Earnings Yield 110.18%
FCF Yield 66.59%

Stock Splits

The last stock split was on January 15, 2020. It was a reverse split with a ratio of 0.1.

Last Split Date Jan 15, 2020
Split Type Reverse
Split Ratio 0.1

Scores

IDXG has an Altman Z-Score of -16.94. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -16.94
Piotroski F-Score n/a